Pfizer (PFE) Capital Expenditures (2009 - 2026)
Pfizer (PFE) recorded Capital Expenditures of $533 million in Q2 2026, down 13.8% from $618 million a year earlier but up 22.2% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Capital Expenditures (2009 - 2026) Analysis & Trends
On a TTM basis, Pfizer's Capital Expenditures came in at $2.42 billion as of Jun 28, 2026, down 12.1% year-over-year; for FY2025, it came in at $2.63 billion, down 9.6% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $2.91 billion in FY2024 (-25.5%), $3.91 billion in FY2023 (+20.7%), $3.24 billion in FY2022 (+19.4%) and $2.71 billion in FY2021 (+21.8%).
- Quarterly Capital Expenditures has ranged from $436 million in Q1 2026 to $1.14 billion in Q1 2023 over the past five years.
- On a year-over-year basis, Capital Expenditures has declined for seven consecutive quarters, with an average decline of 12.4% over the last seven quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 77.1% in Q1 2023, against a decline of 38.2% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $436 million (Q1 2026), $845 million (Q4 2025) and $602 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 112.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 533.00 Mn |
| Mar 29, 2026 | 436.00 Mn |
| Dec 31, 2025 | 845.00 Mn |
| Sep 28, 2025 | 602.00 Mn |
| Jun 29, 2025 | 618.00 Mn |
| Mar 30, 2025 | 564.00 Mn |
| Dec 31, 2024 | 917.00 Mn |
| Sep 29, 2024 | 651.00 Mn |
| Jun 30, 2024 | 637.00 Mn |
| Mar 31, 2024 | 704.00 Mn |
| Dec 31, 2023 | 1.04 Bn |
| Jul 2, 2023 | 914.00 Mn |
| Apr 2, 2023 | 1.14 Bn |
| Dec 31, 2022 | 1.00 Bn |
| Jul 3, 2022 | 751.00 Mn |
| Apr 3, 2022 | 643.00 Mn |
| Dec 31, 2021 | 1.00 Bn |
| Oct 3, 2021 | 618.00 Mn |
| Jul 4, 2021 | 537.00 Mn |
| Apr 4, 2021 | 554.00 Mn |
API Access
Pfizer Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();